Tevosol
About:
Tevosol, a medical device company, has develop the Ex-Vivo Organ Support System to increase the number of available organs for transplant.
Website: http://www.tevosol.com
Twitter/X: tevosol
Top Investors: VA Angels
Description:
Tevosol, Inc. is a medical device company developing the Ex-Vivo Organ Support System (EVOSS™) with the goal of increasing the number of organs available for transplantation. EVOSS™ is a portable warm perfusion device intended to achieve better recovery of organs, better resuscitation of dysfunctional organs, and longer preservation of function with the opportunity for ex-vivo treatment and evaluation. The system consists of a common hardware platform with organ-specific single-use disposable cassettes for lungs, hearts, livers and kidneys.
6M CAD
$1M to $10M
Edmonton, Alberta, Canada
2015-01-01
kevin.ens(AT)tevosol.com
Jayan Nagendran
1-10
2019-08-15
Private
© 2025 bioDAO.ai